444 related articles for article (PubMed ID: 26916014)
1. Gut microbiome and metabolic syndrome.
Mazidi M; Rezaie P; Kengne AP; Mobarhan MG; Ferns GA
Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S150-7. PubMed ID: 26916014
[TBL] [Abstract][Full Text] [Related]
2. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
3. The role of probiotics on each component of the metabolic syndrome and other cardiovascular risks.
Miglioranza Scavuzzi B; Miglioranza LH; Henrique FC; Pitelli Paroschi T; Lozovoy MA; Simão AN; Dichi I
Expert Opin Ther Targets; 2015; 19(8):1127-38. PubMed ID: 25872805
[TBL] [Abstract][Full Text] [Related]
4. Deletion of the Toll-Like Receptor 5 Gene Per Se Does Not Determine the Gut Microbiome Profile That Induces Metabolic Syndrome: Environment Trumps Genotype.
Zhang W; Hartmann R; Tun HM; Elson CO; Khafipour E; Garvey WT
PLoS One; 2016; 11(3):e0150943. PubMed ID: 26950299
[TBL] [Abstract][Full Text] [Related]
5. Nutritional implications in the mechanistic link between the intestinal microbiome, renin-angiotensin system, and the development of obesity and metabolic syndrome.
Guimarães VHD; Marinho BM; Motta-Santos D; Mendes GDRL; Santos SHS
J Nutr Biochem; 2023 Mar; 113():109252. PubMed ID: 36509338
[TBL] [Abstract][Full Text] [Related]
6. Designing future prebiotic fiber to target metabolic syndrome.
Jakobsdottir G; Nyman M; Fåk F
Nutrition; 2014 May; 30(5):497-502. PubMed ID: 24262515
[TBL] [Abstract][Full Text] [Related]
7. 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk.
Tuohy KM; Fava F; Viola R
Proc Nutr Soc; 2014 May; 73(2):172-85. PubMed ID: 24495527
[TBL] [Abstract][Full Text] [Related]
8. Obesity, metabolic syndrome, and microbiota: multiple interactions.
Tilg H
J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S16-8. PubMed ID: 20535027
[TBL] [Abstract][Full Text] [Related]
9. Impact of the gut microbiota on inflammation, obesity, and metabolic disease.
Boulangé CL; Neves AL; Chilloux J; Nicholson JK; Dumas ME
Genome Med; 2016 Apr; 8(1):42. PubMed ID: 27098727
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota: Association with NAFLD and Metabolic Disturbances.
Lau E; Carvalho D; Freitas P
Biomed Res Int; 2015; 2015():979515. PubMed ID: 26090468
[TBL] [Abstract][Full Text] [Related]
11. Establishing a causal link between gut microbes, body weight gain and glucose metabolism in humans - towards treatment with probiotics.
Stenman LK; Burcelin R; Lahtinen S
Benef Microbes; 2016 Feb; 7(1):11-22. PubMed ID: 26565087
[TBL] [Abstract][Full Text] [Related]
12. Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet.
Liu X; Cao S; Zhang X
J Agric Food Chem; 2015 Sep; 63(36):7885-95. PubMed ID: 26306709
[TBL] [Abstract][Full Text] [Related]
13. Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases.
Konturek PC; Haziri D; Brzozowski T; Hess T; Heyman S; Kwiecien S; Konturek SJ; Koziel J
J Physiol Pharmacol; 2015 Aug; 66(4):483-91. PubMed ID: 26348073
[TBL] [Abstract][Full Text] [Related]
14. Contrasting effects of fresh and fermented kimchi consumption on gut microbiota composition and gene expression related to metabolic syndrome in obese Korean women.
Han K; Bose S; Wang JH; Kim BS; Kim MJ; Kim EJ; Kim H
Mol Nutr Food Res; 2015 May; 59(5):1004-8. PubMed ID: 25688926
[TBL] [Abstract][Full Text] [Related]
15. Red wine polyphenols modulate fecal microbiota and reduce markers of the metabolic syndrome in obese patients.
Moreno-Indias I; Sánchez-Alcoholado L; Pérez-Martínez P; Andrés-Lacueva C; Cardona F; Tinahones F; Queipo-Ortuño MI
Food Funct; 2016 Apr; 7(4):1775-87. PubMed ID: 26599039
[TBL] [Abstract][Full Text] [Related]
16. [Probiotics intake as gut-microbiota modulating therapy in an interdisciplinary aspect].
Szydłowska I; Marciniak A; Malanowska E; Nawrocka-Rutkowska J; Brodowska A
Pol Merkur Lekarski; 2020 Aug; 49(286):279-281. PubMed ID: 32827426
[TBL] [Abstract][Full Text] [Related]
17. Triggering Akkermansia with dietary polyphenols: A new weapon to combat the metabolic syndrome?
Anhê FF; Pilon G; Roy D; Desjardins Y; Levy E; Marette A
Gut Microbes; 2016; 7(2):146-53. PubMed ID: 26900906
[TBL] [Abstract][Full Text] [Related]
18. Prebiotic effects: metabolic and health benefits.
Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
[TBL] [Abstract][Full Text] [Related]
19. Alterations in Gut Microbiota and Immunity by Dietary Fat.
Yang BG; Hur KY; Lee MS
Yonsei Med J; 2017 Nov; 58(6):1083-1091. PubMed ID: 29047231
[TBL] [Abstract][Full Text] [Related]
20. Mediterranean diet: the missing link between gut microbiota and inflammatory diseases.
Bifulco M
Eur J Clin Nutr; 2015 Sep; 69(9):1078. PubMed ID: 26014263
[No Abstract] [Full Text] [Related]
[Next] [New Search]
